Physician profile
Dian Yu
NPI 1639527682
$1,536.19
in general payments reported to CMS, 2019-2025
16 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.07 · 2021: $38.23 · 2022: $314 · 2023: $269 · 2024: $495 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $342.87 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $236.93 | 2023-2025 | Hydrus Microstent, Rocklatan, Clareon |
| Sun Pharmaceutical Industries INC. | $195.15 | 2022-2025 | Cequa |
| Oyster Point Pharma, INC. | $119.86 | 2022-2025 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $115.59 | 2022-2023 | |
| Dompe US, INC. | $89.40 | 2022-2025 | Oxervate |
| Biotissue Holdings INC. | $84.37 | 2022-2024 | |
| Kala Pharmaceuticals, INC. | $52.65 | 2021-2022 | |
| Abbvie INC. | $52.27 | 2022 | |
| Amgen INC. | $50.48 | 2025 | Tepezza |
| Harrow Eye, LLC | $49.12 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $46.32 | 2024-2025 | Miebo, Xiidra |
| Mallinckrodt Hospital Products INC. | $33.92 | 2022 | |
| Aerie Pharmaceuticals, INC. | $24.07 | 2019 | |
| Rxsight INC | $23.96 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $19.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dian Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.